About Us
Our team brings proven leadership in healthcare, private equity, and operations, with a successful track record of building and scaling transformative platforms.
Neil Dugdale
A commercial leader with 30+ years driving pharmaceutical growth across European markets. Neil was the former CEO of Flynn Pharma and Interim Commercial Director at Rosemont Pharmaceuticals with global commercial responsibility. Previously, he served at Sobi as Vice President and General Manager, Northern Europe, and General Manager, UK and Ireland; as UK Country Lead at GenSight Biologics; and as Director of Oncology at Merck Serono. Neil has a proven track record building and scaling commercial operations in rare diseases, oncology, and specialty therapeutics across the UK, Ireland, Europe and the Middle East.
Sean Roberts
Sean has more than thirty years’ experience of operating at board level in FTSE 50 companies. He has held key roles which have involved him at very senior levels in strategy development, M&A, technology licensing, corporate regulation, risk management and joint ventures. Sean’s major deals include the merger of GlaxoWellcome and SmithKline Beecham, and creation of global consumer healthcare joint ventures between GSK and both Novartis and Pfizer. Previously, Sean was SVP, General Counsel and Chief Compliance Officer at GSK Consumer Healthcare (now Haleon following its demerger from GSK) and Chief Legal and Corporate Affairs Officer at Imperial Brands. He has extensive expertise building legal and compliance frameworks in complex, regulated global pharma businesses.
Simon Egan
Strategic management and business development entrepreneur with 40+ years transforming complex business scenarios into actionable plans. Founder & CFO of Alverium Health, a contract biotech company with a unique approach to pharmaceutical commercialization. Previously Finance Director and Founding Partner at FleetEurope PLC, Partner at TISE Associates, and Senior Group Manager at Unilever. Extensive expertise in business strategy, M&A, financial management, and building sustainable organizations across healthcare and life sciences.
Ian Crouch
Strategic team builder with 18+ years guiding early-stage biotechs from concept to exit. Played pivotal roles in 10+ transitions including Synageva, Kite, GW Pharmaceuticals, Shire, and Intercept. Partners with CEOs, boards, and investors to design strategic resourcing plans, build executive teams, and orchestrate critical commercial and financial introductions. Deep cross-border experience across US, European, and emerging markets. Currently works with visionary founders developing breakthrough therapies, building leadership capacity for global scale and strategic transactions.
Nick Plumeridge
Life science executive with 30+ years in global pharmaceutical business development and M&A. Former Royal Navy officer, subsequently held senior roles at Aventis, Serono, Takeda, Quintiles, Epirus, and mAbxience. Led major transactions including Nycomed and Valeant acquisitions, plus JV's and licensing deals across biologics and small molecules. Currently independent consultant focused on early-stage strategies, partnerships, and alliances for biotech startups and academic spin-outs across Europe, North America, Asia Pacific, and emerging markets.
Jamie Hawkes
Jamie is a technical executive with 20+ years in personal care and speciality chemical product development. Previously, he was Global Head of Hair Care Technology at Lonza, and Technical and Operations Director at Perachem Ltd. A recognised innovator with 36 granted patents, 31 pending applications and 30 peer reviewed articles, he has extensive expertise in R&D leadership, innovation, technology commercialisation, manufacturing processes, regulatory compliance, IP strategy and leading multicultural teams to bring disruptive technologies from concept to market.
Gal Kaspi
Operations and supply chain executive with 17+ years in pharmaceutical manufacturing and generics. General Manager at Medibrane, previously Head of End-to-End Product Strategy and Head of Third Party Make vs Buy Strategy at Teva Pharmaceuticals. Led cross-organizational business processes, product lifecycle management, and strategic decision-making across global operations. Extensive expertise in process improvement, supply chain optimization, quality systems, and driving operational excellence in pharmaceutical manufacturing.
Mike Hoang
Healthcare technology executive with 15+ years commercializing precision medicine and diagnostics platforms. Senior Director at Endpoint Health building precision-first therapeutics, previously led product management and commercialization at Roche, Life Technologies, and Beckman Coulter having launched 10+ successful products. Founded Scriptyx connecting patient outcomes data with pharma insights. Extensive expertise in strategic marketing, product lifecycle management, business development, and launching disruptive technologies.
Lina Cogan
Pharmaceutical executive with 20+ years in business development, strategic sourcing, and commercial operations across APIs and drug manufacturing. Co-founder at CollaBio Healthcare leading strategic acquisition initiatives in EU. Previously Corporate Head of Business Development at ABA Chemicals, Senior Director Global Sourcing at LGM Pharma, and Director roles at Teva Pharmaceuticals managing $900M+ globally. Extensive expertise in transformation, market expansion, M&A, and optimizing procurement and supply chain operations.
© 2026 Collabio Collaborative Healthcare (UK Holdings) Limited. All rights reserved.
